Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Journal of Surgical Oncology
|
September 11, 2020
Predicting malignancy in patients with adrenal tumors using <sup>18</sup> F-FDG-PET/CT SUVmax
Elvira L Vos, Ravinder K Grewal, Ashley E Russo, et al.
The Journal of Clinical Investigation
|
November 8, 2011
Activation of K(ATP) channels suppresses glucose production in humans
Preeti Kishore, Laura Boucai, Kehao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2023
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
Laura Boucai, Mahesh Saqcena, Fengshen Kuo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 26, 2019
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases
Dilmi Perera, Ronald Ghossein, Niedzica Camacho, et al.
The Lancet. Diabetes & Endocrinology
|
May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
The Journal of Clinical Investigation
|
February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
The Journal of Clinical Investigation
|
August 19, 2025
Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 30, 2022
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns
Robert Michael Tuttle, James Fagin, Gerald Minkowitz, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 1, 2017
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
R Michael Tuttle, James A Fagin, Gerald Minkowitz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Journal of Surgical Oncology
|
September 11, 2020
Predicting malignancy in patients with adrenal tumors using <sup>18</sup> F-FDG-PET/CT SUVmax
Elvira L Vos, Ravinder K Grewal, Ashley E Russo, et al.
The Journal of Clinical Investigation
|
November 8, 2011
Activation of K(ATP) channels suppresses glucose production in humans
Preeti Kishore, Laura Boucai, Kehao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2023
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy
Laura Boucai, Mahesh Saqcena, Fengshen Kuo, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 26, 2019
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node Metastases
Dilmi Perera, Ronald Ghossein, Niedzica Camacho, et al.
The Lancet. Diabetes & Endocrinology
|
May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
The Journal of Clinical Investigation
|
February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Biorxiv : the Preprint Server for Biology
|
March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
The Journal of Clinical Investigation
|
August 19, 2025
Loss of tumor cell MHC Class II drives MAPK-inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 30, 2022
Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns
Robert Michael Tuttle, James Fagin, Gerald Minkowitz, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 1, 2017
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
R Michael Tuttle, James A Fagin, Gerald Minkowitz, et al.
Page
of 6